Skip to content

Tempus AI, Inc. TEM Price / book

Price / book at other companies

IQVIA logo
IQVIAIQV
4.6×-0.6×
Guardant Health logo
Guardant HealthGH
36.8×
Natera, Inc. logo
Natera, Inc.NTRA
16×+0.6×
Revvity logo
RevvityRVTY
1.4×-0.3×
Agilent Technologies logo
Agilent TechnologiesA
4.6×-0.4×
TEC
Bio-TechneTECH
3.9×-0.7×

Other financials

Income statement

See full
Revenue$348.1M+36.1%
Operating income-$84.7M-23.3%
Net income-$125.9M-85.1%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$525.9M+243%
Total debt$85.4M+49.8%
Total equity$416.4M+27.7%
Total assets$2.1B+38.4%

Cash flow

See full
Operating cash flow-$73.3M+30.6%
CapEx$8.2M+295%
Free cash flow-$81.5M+24.3%

Valuation

See full
Market cap$9.13B-2.7%
Enterprise value$8.69B-6.9%
P/S6.7×-5.0×

Profitability

See full
Operating margin-19.7%-8.6pp
Net margin-22.2%-9.5pp
FCF margin-54.5%

Returns & leverage

See full
Return on equity-81.6%
Debt / equity0.2×0.0×
Current ratio3.3×+1.6×

Where this comes from

Calculated from Tempus AI, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tempus AI, Inc.'s price / book?
Tempus AI, Inc. (TEM) reported price / book of 19.4× in Q1 2026.
How has Tempus AI, Inc.'s price / book changed year-over-year?
Tempus AI, Inc.'s price / book decreased by 23.8% year-over-year, from 25.5× to 19.4×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.